BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RB-ADSC readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RB-ADSC\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07373067-748@assetmemo.bio
DTSTAMP:20261121T005838Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:RB-ADSC: Phase 1 readout est. (NCT07373067)
DESCRIPTION:RB-ADSC\, phase 1\, Alzheimer's Disease.\nStudy: Repeat Intrace
 rebroventricular Injections of RB-ADSC in Subjects Previously Treated in R
 BI Protocol RB-ADSC-02\nEstimated primary completion: September 2028. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/rb-adsc#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT07373067
URL:https://assetmemo.bio/drug/rb-adsc#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07205601-748@assetmemo.bio
DTSTAMP:20261121T005838Z
DTSTART;VALUE=DATE:20290228
DTEND;VALUE=DATE:20290301
SUMMARY:RB-ADSC: Phase 2 readout est. (NCT07205601)
DESCRIPTION:RB-ADSC\, phase 2\, Alzheimer's Disease.\nStudy: Study of Intra
 cerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB
 -ADSCs) in Participants With Mild-Moderate Alzheimer's Disease\nEstimated 
 primary completion: February 2029. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/rb-adsc#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07205601
URL:https://assetmemo.bio/drug/rb-adsc#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
